Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC.
Nat Commun
; 10(1): 4681, 2019 10 15.
Article
in En
| MEDLINE
| ID: mdl-31615983
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Drug Resistance, Neoplasm
/
Phosphoglycerate Dehydrogenase
/
Sorafenib
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Limits:
Humans
Language:
En
Year:
2019
Type:
Article